• Silexion Therapeutics shareholders backed an amendment to its Cayman Islands memorandum, lifting authorized share capital.
• The change was adopted at an extraordinary general meeting held July 13, 2026, then reconvened July 20, 2026.
• The amendment took effect July 21, 2026, upon filing with the Cayman Islands Registrar of Companies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silexion Therapeutics Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-003551), on July 21, 2026, and is solely responsible for the information contained therein.